Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls
2022-01-01 Morganti, S.; Ivanova, M.; Ferraro, E.; Ascione, L.; Vivanet, G.; Bonizzi, G.; Curigliano, G.; Fusco, N.; Criscitiello, C.
[Exemestane in the treatment of breast carcinoma: recent findings]
2008-01-01 De Laurentiis, M; Criscitiello, C; Montanino, A; Falato, C; Plaitano, M
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
2019-01-01 Park, J H; Jonas, S F; Bataillon, G; Criscitiello, C; Salgado, R; Loi, S; Viale, G; Lee, H J; Dieci, M V; Kim, S-B; Vincent-Salomon, A; Curigliano, G; André, F; Michiels, S
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
2016-01-01 Pruneri, G; Gray, Kp; Vingiani, A; Viale, G; Curigliano, G; Criscitiello, C; Láng, I; Ruhstaller, T; Gianni, L; Goldhirsch, A; Kammler, R; Price, Kn; Cancello, G; Munzone, E; Gelber, Rd; Regan, Mm; Colleoni, M
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
2024-01-01 Valenza, Carmine; Trapani, Dario; Zagami, Paola; Antonarelli, Gabriele; Boscolo Bielo, Luca; Nicolò, Eleonora; Ribeiro, Joana Mourato; Guidi, Lorenzo; Reduzzi, Carolina; Spotti, Martina; Adamoli, Laura; Cortès, Javier; Pistilli, Barbara; Tolaney, Sara M.; Ueno, Naoto; Layman, Rachel M.; Cristofanilli, Massimo; Carey, Lisa A.; Munzone, Elisabetta; Criscitiello, Carmen; Lynce, Filipa; Woodward, Wendy A.; Curigliano, Giuseppe
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
2024-01-01 Boscolo Bielo, L.; Guerini Rocco, E.; Trapani, D.; Zagami, P.; Taurelli Salimbeni, B.; Esposito, A.; Belli, C.; Crimini, E.; Venetis, K.; Munzone, E.; Fusco, N.; Criscitiello, C.; Marra, A.; Curigliano, G.
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
2023-01-01 Fabi, Alessandra; Carbognin, Luisa; Botticelli, Andrea; Paris, Ida; Fuso, Paola; Savastano, Maria Cristina; La Verde, Nicla; Strina, Carla; Pedersini, Rebecca; Guarino, Stefania; Curigliano, Giuseppe; Criscitiello, Carmen; Raffaele, Mimma; Beano, Alessandra; Franco, Antonio; Valerio, Maria Rosaria; Verderame, Francesco; Fontana, Andrea; Haspinger, Eva Regina; Caldara, Alessia; Di Leone, Alba; Tortora, Giampaolo; Giannarelli, Diana; Scambia, Giovanni
Pten alterations and their role in cancer management: Are we making headway on precision medicine?
2020-01-01 Fusco, N.; Sajjadi, E.; Venetis, K.; Gaudioso, G.; Lopez, G.; Corti, C.; Guerini Rocco, E.; Criscitiello, C.; Malapelle, U.; Invernizzi, M.
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology
2025-01-01 Giugliano, Federica; Giordano, Elisa; Gilardi, Laura; Salimbeni, Beatrice Taurelli; Zagami, Paola; Esposito, Angela; Marra, Antonio; Trapani, Dario; Berton Giachetti, Pier Paolo Maria; Malagutti, Bianca; Henry, Théophraste; Deandreis, Desiree; Curigliano, Giuseppe; Ceci, Francesco; Criscitiello, Carmen
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines
2012-01-01 Curigliano, G.; Cardinale, D.; Suter, T.; Plataniotis, G.; De Azambuja, E.; Sandri, M. T.; Criscitiello, C.; Goldhirsch, A.; Cipolla, C.; Roila, F.
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
2025-01-01 Berton Giachetti, Pier Paolo Maria; Morganti, Stefania; Gandini, Sara; Giudici, Fabiola; Marra, Antonio; Nicolò, Eleonora; Zattarin, Emma; Corti, Chiara; Boldrini, Laura; Verrazzo, Annarita; Sposetti, Caterina; Razeti, Maria Grazia; Carnevale Schianca, Ambra; Scafetta, Roberta; Taurelli Salimbeni, Beatrice; Esposito, Angela; Zagami, Paola; Trapani, Dario; Malagutti, Bianca; Caputo, Roberta; Vernieri, Claudio; Munzone, Elisabetta; Scagnoli, Simone; Botticelli, Andrea; Lambertini, Matteo; Giuliano, Mario; De Laurentiis, Michelino; Viale, Giulia; Bianchini, Giampaolo; Curigliano, Giuseppe; De Angelis, Carmine; Criscitiello, Carmen
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis
2018-01-01 Criscitiello, Carmen; Golshan, Mehra; Barry, William T.; Viale, Giulia; Wong, Stephanie; Santangelo, Michele; Curigliano, Giuseppe
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018-01-01 Trapani, D.; Viale, G.; Criscitiello, C.; Paolo, D'Amico; Belli, C.; Mazzarella, L.; Locatelli, M.; Minchella, I.; Curigliano, G.; Bruno, Achutti Duso
Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting
2017-01-01 Criscitiello, Carmen; Carmen*;, Viale; Giulia;, Curigliano
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
2018-01-01 Malorni, L.; Curigliano, G.; Minisini, A. M.; Cinieri, S.; Tondini, C. A.; D'Hollander, K.; Arpino, G.; Bernardo, A.; Martignetti, A.; Criscitiello, C.; Puglisi, F.; Pestrin, M.; Sanna, G.; Moretti, E.; Risi, E.; Biagioni, C.; Mccartney, A.; Boni, L.; Buyse, M.; Migliaccio, I.; Biganzoli, L.; Di Leo, A.
Tumor-stroma crosstalk: targeting stroma in breast cancer
2014-01-01 Criscitiello, C; Esposito, A; Curigliano, G
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists
2021-01-01 Fusco, N.; Ragazzi, M.; Sajjadi, E.; Venetis, K.; Piciotti, R.; Morganti, S.; Santandrea, G.; Fanelli, G. N.; Despini, L.; Invernizzi, M.; Cerbelli, B.; Scatena, C.; Criscitiello, C.
Editorial : Diagnosis and Treatment of Breast Cancer in 2022 : The Rise of Novel Molecular Biomarkers
2023-01-01 Fusco, N.; Malapelle, U.; Criscitiello, C.
Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review
2016-01-01 Santangelo, Ml; Grifasi, C; Criscitiello, C; Giuliano, M; Calogero, A; Dodaro, C; Incollingo, P; Rupealta, N; Candida, M; Chiacchio, G; Riccio, E; Pisani, A; Tammaro, V; Carlomagno, N
Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow
2024-01-01 Cobanaj, M.; Corti, C.; Dee, E. C.; Mccullum, L.; Boldrini, L.; Schlam, I.; Tolaney, S. M.; Celi, L. A.; Curigliano, G.; Criscitiello, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls | 1-gen-2022 | Morganti, S.; Ivanova, M.; Ferraro, E.; Ascione, L.; Vivanet, G.; Bonizzi, G.; Curigliano, G.; Fusco, N.; Criscitiello, C. | |
| [Exemestane in the treatment of breast carcinoma: recent findings] | 1-gen-2008 | De Laurentiis, M; Criscitiello, C; Montanino, A; Falato, C; Plaitano, M | |
| Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy | 1-gen-2019 | Park, J H; Jonas, S F; Bataillon, G; Criscitiello, C; Salgado, R; Loi, S; Viale, G; Lee, H J; Dieci, M V; Kim, S-B; Vincent-Salomon, A; Curigliano, G; André, F; Michiels, S | |
| Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00 | 1-gen-2016 | Pruneri, G; Gray, Kp; Vingiani, A; Viale, G; Curigliano, G; Criscitiello, C; Láng, I; Ruhstaller, T; Gianni, L; Goldhirsch, A; Kammler, R; Price, Kn; Cancello, G; Munzone, E; Gelber, Rd; Regan, Mm; Colleoni, M | |
| Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study | 1-gen-2024 | Valenza, Carmine; Trapani, Dario; Zagami, Paola; Antonarelli, Gabriele; Boscolo Bielo, Luca; Nicolò, Eleonora; Ribeiro, Joana Mourato; Guidi, Lorenzo; Reduzzi, Carolina; Spotti, Martina; Adamoli, Laura; Cortès, Javier; Pistilli, Barbara; Tolaney, Sara M.; Ueno, Naoto; Layman, Rachel M.; Cristofanilli, Massimo; Carey, Lisa A.; Munzone, Elisabetta; Criscitiello, Carmen; Lynce, Filipa; Woodward, Wendy A.; Curigliano, Giuseppe | |
| Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations | 1-gen-2024 | Boscolo Bielo, L.; Guerini Rocco, E.; Trapani, D.; Zagami, P.; Taurelli Salimbeni, B.; Esposito, A.; Belli, C.; Crimini, E.; Venetis, K.; Munzone, E.; Fusco, N.; Criscitiello, C.; Marra, A.; Curigliano, G. | |
| Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer | 1-gen-2023 | Fabi, Alessandra; Carbognin, Luisa; Botticelli, Andrea; Paris, Ida; Fuso, Paola; Savastano, Maria Cristina; La Verde, Nicla; Strina, Carla; Pedersini, Rebecca; Guarino, Stefania; Curigliano, Giuseppe; Criscitiello, Carmen; Raffaele, Mimma; Beano, Alessandra; Franco, Antonio; Valerio, Maria Rosaria; Verderame, Francesco; Fontana, Andrea; Haspinger, Eva Regina; Caldara, Alessia; Di Leone, Alba; Tortora, Giampaolo; Giannarelli, Diana; Scambia, Giovanni | |
| Pten alterations and their role in cancer management: Are we making headway on precision medicine? | 1-gen-2020 | Fusco, N.; Sajjadi, E.; Venetis, K.; Gaudioso, G.; Lopez, G.; Corti, C.; Guerini Rocco, E.; Criscitiello, C.; Malapelle, U.; Invernizzi, M. | |
| Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology | 1-gen-2025 | Giugliano, Federica; Giordano, Elisa; Gilardi, Laura; Salimbeni, Beatrice Taurelli; Zagami, Paola; Esposito, Angela; Marra, Antonio; Trapani, Dario; Berton Giachetti, Pier Paolo Maria; Malagutti, Bianca; Henry, Théophraste; Deandreis, Desiree; Curigliano, Giuseppe; Ceci, Francesco; Criscitiello, Carmen | |
| Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines | 1-gen-2012 | Curigliano, G.; Cardinale, D.; Suter, T.; Plataniotis, G.; De Azambuja, E.; Sandri, M. T.; Criscitiello, C.; Goldhirsch, A.; Cipolla, C.; Roila, F. | |
| Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer | 1-gen-2025 | Berton Giachetti, Pier Paolo Maria; Morganti, Stefania; Gandini, Sara; Giudici, Fabiola; Marra, Antonio; Nicolò, Eleonora; Zattarin, Emma; Corti, Chiara; Boldrini, Laura; Verrazzo, Annarita; Sposetti, Caterina; Razeti, Maria Grazia; Carnevale Schianca, Ambra; Scafetta, Roberta; Taurelli Salimbeni, Beatrice; Esposito, Angela; Zagami, Paola; Trapani, Dario; Malagutti, Bianca; Caputo, Roberta; Vernieri, Claudio; Munzone, Elisabetta; Scagnoli, Simone; Botticelli, Andrea; Lambertini, Matteo; Giuliano, Mario; De Laurentiis, Michelino; Viale, Giulia; Bianchini, Giampaolo; Curigliano, Giuseppe; De Angelis, Carmine; Criscitiello, Carmen | |
| Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis | 1-gen-2018 | Criscitiello, Carmen; Golshan, Mehra; Barry, William T.; Viale, Giulia; Wong, Stephanie; Santangelo, Michele; Curigliano, Giuseppe | |
| Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer | 1-gen-2018 | Trapani, D.; Viale, G.; Criscitiello, C.; Paolo, D'Amico; Belli, C.; Mazzarella, L.; Locatelli, M.; Minchella, I.; Curigliano, G.; Bruno, Achutti Duso | |
| Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting | 1-gen-2017 | Criscitiello, Carmen; Carmen*;, Viale; Giulia;, Curigliano | |
| Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial | 1-gen-2018 | Malorni, L.; Curigliano, G.; Minisini, A. M.; Cinieri, S.; Tondini, C. A.; D'Hollander, K.; Arpino, G.; Bernardo, A.; Martignetti, A.; Criscitiello, C.; Puglisi, F.; Pestrin, M.; Sanna, G.; Moretti, E.; Risi, E.; Biagioni, C.; Mccartney, A.; Boni, L.; Buyse, M.; Migliaccio, I.; Biganzoli, L.; Di Leo, A. | |
| Tumor-stroma crosstalk: targeting stroma in breast cancer | 1-gen-2014 | Criscitiello, C; Esposito, A; Curigliano, G | |
| Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists | 1-gen-2021 | Fusco, N.; Ragazzi, M.; Sajjadi, E.; Venetis, K.; Piciotti, R.; Morganti, S.; Santandrea, G.; Fanelli, G. N.; Despini, L.; Invernizzi, M.; Cerbelli, B.; Scatena, C.; Criscitiello, C. | |
| Editorial : Diagnosis and Treatment of Breast Cancer in 2022 : The Rise of Novel Molecular Biomarkers | 1-gen-2023 | Fusco, N.; Malapelle, U.; Criscitiello, C. | |
| Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review | 1-gen-2016 | Santangelo, Ml; Grifasi, C; Criscitiello, C; Giuliano, M; Calogero, A; Dodaro, C; Incollingo, P; Rupealta, N; Candida, M; Chiacchio, G; Riccio, E; Pisani, A; Tammaro, V; Carlomagno, N | |
| Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow | 1-gen-2024 | Cobanaj, M.; Corti, C.; Dee, E. C.; Mccullum, L.; Boldrini, L.; Schlam, I.; Tolaney, S. M.; Celi, L. A.; Curigliano, G.; Criscitiello, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26266
Data di pubblicazione
- In corso di stampa10
- 2020 - 20268444
- 2010 - 201911540
- 2000 - 20094513
- 1990 - 19991428
- 1980 - 1989308
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE358
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
- ANNALS OF ONCOLOGY239
- CANCERS223
- THE JOURNAL OF NUCLEAR MEDICINE221
- PLOS ONE211
- EUROPEAN JOURNAL OF CANCER197
- GASTROINTESTINAL ENDOSCOPY193
- ALLERGY178
- JOURNAL OF CLINICAL ONCOLOGY169
Keyword
- Humans2102
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19408
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng18439
- ita405
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
- und1
Accesso al fulltext
- no fulltext24066
- reserved1312
- open888